Ovarian metastases from colorectal carcinoma: Clinicopathologic profile, immunophenotype, and karyotype analysis

American Journal of Clinical Pathology

Volumn 114, Issue 1, 2000, Pages 111-122

  Dionigi, Adriana ^a   Facco, Carla ^a   Tibiletti, Maria Grazia ^a   Bernasconi, Barbara ^a   Riva, Cristina ^a   Capella, Carlo ^a  

^a Ospedale Multizonale Varese   (Italy)

Author keywords

Chromosome 13; Colon carcinoma; FISH; Fluorescence in situ hybridization; Immunohistochemistry; Ovarian metastasis

Indexed keywords

CA 125 ANTIGEN; CATHEPSIN E; CYTOKERATIN 20; CYTOKERATIN 7; ESTROGEN; ESTROGEN RECEPTOR; INHIBIN; PROGESTERONE; PROGESTERONE RECEPTOR; TUMOR MARKER; VIMENTIN;

ADULT; AGED; ARTICLE; CHROMOSOME 13Q; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KARYOTYPING; MITOSIS INDEX; OVARY CARCINOMA; OVARY METASTASIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COLORECTAL NEOPLASMS; CYTOGENETICS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MIDDLE AGED; OVARIAN NEOPLASMS;

EID: 0034582150     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/G56H-97A2-JFMT-CD5N     Document Type: Article

References (26)

1. Metastatic tumors in the ovary: A problem-oriented approach and review of the recent literature
2. Secondary ovarian carcinoma: A clinical and pathological evaluation
3. Metastatic ovarian carcinoma of large intestinal origin simulating primary ovarian carcinoma: A clinicopathologic study of 25 cases
4. Metastatic tumors of the ovary
5. Intestinal adenocarcinomas metastatic to the ovaries: A clinico-pathologic evaluation of 22 cases
6. Characterization of the CA125 antigen associated with human epithelial ovarian carcinomas
7. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC 125
8. Carcino-embryonic antigen (CEA) and carbohydrate determinant 19-9 (CA19-9) localization in 121 primary and metastatic ovarian tumors: An immunohistochemical study with the use of monoclonal antibodies
9. Immunohistochemical study of cytokeratin 7 for the differential diagnosis of adenocarcinomas in the ovary
10. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary
11. Necrosis in 84 ovarian carcinomas: A morphological study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen
12. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques
13. Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary
14. Early involvement of 6q in surface epithelial ovarian tumors
15. A large 6q deletion is a common cytogenetic alteration in fibroadenomas, premalignant lesions and carcinomas of the breast
16. Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization
17. Krukenberg tumors of the ovary: A clinicopathologic analysis of 27 cases
18. Tubular Krukenberg tumor: A problem in histopathologic diagnosis
19. Secondary ovarian neoplasia: A clinicopathologic study of 35 cases
20. Clinical aspects of metastatic ovarian cancer of extragenital origin
21. Ovarian mucinous tumors frequently express markers of gastric, intestinal, and pancreatobiliary epithelial cells
22. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin: Comparison between a statistical and an intuitive approach
23. Chromosome aberrations in 35 primary ovarian carcinomas
24. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization
25. Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation